Click image to view original image
Natural Weight Loss Drug Rimonabant / Acomplia For Fat Burning 168273-06-1
Email: kristin@kafenbio.com
WhatsApp: +8618026323273
Skype:steroid-supplier
1.Quick Detail:
Product Name: Rimonabant
Chemical Name: Acomplia
CAS:168273-06-1
Molecular Formula: C22H21Cl3N4O
Molecular Weight:463.79
Assay: 99.5%
Appearance:white powder
Payment Terms:TT, Western unio, Money Gram,Bitcoin
2.Product Description:
Rimonabant is the generic name for Acomplia, which is an appetite suppressant and smoking cessation product manufactured by the French pharmaceutical company Sanofi-Aventis.Rimonabant is a cannabinoid (CB1) receptor antagonist, which means it blocks CB1 receptors in the brain and peripheral organs, which is said to suppress appetite and possibly reduce tobacco dependence.
Rimonabant (Acomplia) acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle2.Rimonabant (Acomplia) switches off the same brain circuits that make people hungry when they smoke cannabis.
CB1 receptor blockade with Rimonabant (Acomplia) acts to decrease the overactivity of the endocannabinoid system (EC system). 3,4 The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
3.Product Function:
Rimonabant (Acomplia) was studied to be used complementary to diet and exercise to treat obese or overweight patients who suffer from type 2 diabetes and abnormal levels of fat in the blood.Sanofi argued that Acomplia could also prevent the risk of cardiovascular disease.Patients with large waist circumference (102 cm in men and 88 cm in women) were said to most benefit from taking the drug.
Rimonabant (Acomplia) (Zimulti in the US) was studied by Sanofi-Aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking.
Sanofi-Aventis submitted a New Drug Application to the FDA, which in turn issued a non-approvable letter for Zimulti for use in smoking cessation. In June of 2007, the FDA's Endocrine and metabolic Drugs Advisory Committee recommended against the approval of rimonabant due to concerns over serious side effects such as suicidality.
4.Our Advantages
High quality with competitive price
1)Standard: Enterprise Standard
2)We are manufacturer and can provide high quality products with factory price.
3)Quality can be promised. Hot sell to Worldwide.
Fast and safe delivery
1)Parcel can be sent out in 24 hours after payment. Tracking number is available.
2)Secure and discreet shipment. Various transportation methods for your choice.
3)We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.
4)Tracking your order at any time. Inform your order's further new situation at any time.
Our clients throughout the world.
1)Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2)Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
3) High quality, competitive price, fast delivery, first class service gain the trust and praise from the customers.
